Innovation1 Biotech Inc.
IVBT
Rank in Stocks
#34615
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily... Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical conditions. Specifically, these include a psychedelic compound derived from mushrooms, aimed at treating post-traumatic stress disorder and depression; an innovative cannabinoid and tree bark-sourced psychedelic intended to combat addiction; and three additional cannabinoid prodrugs targeting refractory pediatric epilepsy, hypertrophic scarring, and inflammation of the eye. Established in 2014 and headquartered in New York, New York, the company was previously named Gridiron BioNutrients, Inc. before adopting its current moniker, Innovation1 Biotech Inc., in March 2022.
Share Price
$0.0002
Last synced: 2026-11-19
Market Cap
$4.49K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Innovation1 Biotech Inc. (IVBT)
Category
Healthcare
EPS for Innovation1 Biotech Inc. (IVBT)
EPS as of February 2024 TTM: $-0.31
According to Innovation1 Biotech Inc.'s latest financial reports, its current EPS (TTM) is $-0.31. At the end of 2023 the company had an EPS of $-0.70, an increase over its 2022 EPS of $-2.73.
EPS history for Innovation1 Biotech Inc. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.31 | -55.71% |
| 2023 | $-0.70 | -74.36% |
| 2022 | $-2.73 | -149.37% |
| 2021 | $5.53 | -164.38% |
| 2020 | $-8.59 | 2,102.56% |
| 2019 | $-0.39 | -48.00% |
| 2018 | $-0.75 | 275.00% |
| 2017 | $-0.20 | 0.00% |
| 2016 | $-0.20 | 135.29% |
| 2015 | $-0.09 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -5,151.61% |
US
|
|
| $-7.07 | 2,180.65% |
US
|
|
| $-5.29 | 1,606.45% |
AU
|
|
| $12.73 | -4,207.16% |
BE
|
|
| $21.56 | -7,054.84% |
NL
|
Questions about Innovation1 Biotech Inc.'s earnings per share (EPS)
What is Innovation1 Biotech Inc.'s earnings per share (EPS)?
Innovation1 Biotech Inc.'s earnings per share (EPS) over the last twelve months is $-0.31, as of Feb 2024.
What was Innovation1 Biotech Inc.'s earnings per share (EPS) in 2023?
In 2023, Innovation1 Biotech Inc.'s earnings per share (EPS) was $-0.70, compared with $-2.73 in 2022.
How has Innovation1 Biotech Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Innovation1 Biotech Inc.'s earnings per share (EPS) was highest in 2021 ($5.53) and lowest in 2020 ($-8.59).
How does Innovation1 Biotech Inc.'s earnings per share (EPS) compare with similar companies?
Innovation1 Biotech Inc.'s earnings per share (EPS) ($-0.31) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.